Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL


Share

Program Content

Activities

  • Managing CLL and MCL With BTKi
    Current and Emerging Roles of BTK Inhibitors in CLL/SLL and MCL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 13, 2023

    View Activity

Faculty

cover img faculity

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Nurse Practitioner
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio